InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.00
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
63,763.58
(
0.56%
)
Post# of 4966635
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Natural Trader

Send PM Follow Ignore
Followers 493
Posts 30517
Boards Moderated 3
Alias Born 01/31/2008

Natural Trader

Re: Zardiw post# 4962982

Thursday, 03/21/2024 11:35:07 AM

Thursday, March 21, 2024 11:35:07 AM

Post# of 4966635
$BTTX .013 :In February 2024, the FDA granted Better Therapeutics Breakthrough Device Designation for its novel Cognitive Behavioral Therapy (CBT) platform intended to treat adults with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH. We are actively seeking strategic partnerships to expedite the development and commercialization of this therapy.

All posts are my opinion and are not recommendations to buy or sell

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up